Peers Price Chg Day Year Date
Matsui Securities 929.00 -17.00 -1.80% 14.69% Feb/12
Acacia Research 4.06 -0.05 -1.22% -3.79% Feb/11
Brinks 130.73 -0.76 -0.58% 40.34% Feb/11
Capita 366.00 -15.00 -3.94% 77.93% Feb/11
CRA International 164.10 -9.80 -5.64% -13.17% Feb/11
Cintas 200.30 0.99 0.50% -2.11% Feb/11
Exponent 71.72 -4.43 -5.82% -20.77% Feb/11
Franklin Covey 367.45 2.68 0.73% 38.67% Feb/11
Forrester Research 6.56 -0.41 -5.88% -50.57% Feb/11
Genpact 37.18 -1.96 -5.01% -32.28% Feb/11

Indexes Price Day Year Date
USND 23066 -36.01 -0.16% 17.39% Feb/11
US2000 2669 -10.30 -0.38% 18.33% Feb/11

Acacia Research traded at $4.06 this Wednesday February 11th, decreasing $0.05 or 1.22 percent since the previous trading session. Looking back, over the last four weeks, Acacia Research lost 4.10 percent. Over the last 12 months, its price fell by 3.79 percent. Looking ahead, we forecast Acacia Research to be priced at 5.04 by the end of this quarter and at 4.59 in one year, according to Trading Economics global macro models projections and analysts expectations.

Acacia Research Corporation, through its subsidiaries, invests in, licenses and enforces patented technologies. The Company's operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. The Company's operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The Company's operating subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a range of industries.